Trifluridine/tipiracil(TAS-102)-induced nausea and vomiting in patients with colorectal cancer: a prospective, observational, multicenter study
收藏NIAID Data Ecosystem2026-03-11 收录
官方服务：
资源简介：
Primary outcome(s): Incidence of vomiting during the 14 days after starting TAS-102
创建时间：
2020-01-15
